TruNativ bags $30M Series B led by OrbiMed to scale clean-label nutrition play

Mumbai-based D2C nutrition brand TruNativ has raised $30M in Series B (primary + secondary) led by OrbiMed. Capital will fund expansion across D2C, quick commerce, modern trade, and pharmacy, plus growth of its B2B2C ingredient business spanning sugar substitutes, protein, gut health, and wellness.

— Filed Tue, 16 Jun, 2026, 19:55 IST · Source YourStory · Updated

Mumbai-based clean-label nutrition D2C brand TruNativ raised $30M Series B led by OrbiMed (primary plus secondary). Funds will scale distribution across D2C, quick commerce, modern trade, pharmacy, and expand its B2B2C ingredient business across sugar substitutes, protein, gut health, and wellness.

Also reported by